Cellectar Biosciences (CLRB)
(Delayed Data from NSDQ)
$1.92 USD
-0.08 (-4.00%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.92 0.00 (0.00%) 7:26 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 28% (70 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.69 | 9.99 |
Current Quarter Estimate | -0.23 | 1.28 | 61.00 |
Year Ago Quarter Estimate | -0.73 | 2.71 | 54.84 |
Next Quarter Estimate | -0.35 | 7.55 | 63.00 |
Next Year Estimate | -0.25 | 45.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 39.37 | 12.70 | 15.67 |
Next Year | 86.91 | 22.20 | 11.34 |
Last 5 Years | NA | 2.90 | 8.10 |
Next 5 Years | NA | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 4.88 |
Price/Book (MRQ) | 7.89 | 2.24 |
Price/Cash Flow (MRFY) | NA | 11.85 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -9.36% |
Return on Equity (TTM) | NA | -2.30% |
Debt to Equity (MRQ) | NA | 22.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.